Harlan Pinto

3.8k total citations · 1 hit paper
28 papers, 2.9k citations indexed

About

Harlan Pinto is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Harlan Pinto has authored 28 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Otorhinolaryngology, 12 papers in Surgery and 11 papers in Oncology. Recurrent topics in Harlan Pinto's work include Head and Neck Cancer Studies (17 papers), Head and Neck Surgical Oncology (5 papers) and Cancer Diagnosis and Treatment (4 papers). Harlan Pinto is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Head and Neck Surgical Oncology (5 papers) and Cancer Diagnosis and Treatment (4 papers). Harlan Pinto collaborates with scholars based in United States. Harlan Pinto's co-authors include Anthony J. Cmelak, S. Li, John A. Ridge, William H. Westra, Carole Fakhry, M. L. Gillison, A. Forastiere, Quynh‐Thu Le, Michael J. Kaplan and Don R. Goffinet and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Harlan Pinto

27 papers receiving 2.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

2008 2.1k citations Carole Fakhry, William H. Westra et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harlan Pinto United States	14	2.2k	1.3k	1.0k	685	459	28	2.9k
Harold E. Kim United States	15	2.5k 1.1×	1.7k 1.3×	1.2k 1.2×	1.1k 1.6×	485 1.1×	17	3.4k
S. Jelić Serbia	20	968 0.4×	987 0.7×	1.4k 1.4×	838 1.2×	310 0.7×	70	2.7k
Sing Fai Leung Hong Kong	21	1.6k 0.7×	1.1k 0.8×	1.1k 1.1×	712 1.0×	366 0.8×	41	2.4k
Caroline Even France	22	853 0.4×	692 0.5×	1.8k 1.7×	812 1.2×	332 0.7×	142	2.5k
Meredith A. Goldwasser United States	17	670 0.3×	558 0.4×	1.4k 1.4×	969 1.4×	875 1.9×	29	2.7k
Nicole G. Chau United States	24	495 0.2×	798 0.6×	1.3k 1.2×	449 0.7×	640 1.4×	80	2.3k
Assuntina G. Sacco United States	23	550 0.3×	525 0.4×	787 0.8×	588 0.9×	329 0.7×	60	1.8k
Bidhu Kalyan Mohanti India	24	372 0.2×	683 0.5×	717 0.7×	799 1.2×	237 0.5×	126	1.9k
Peter Choi China	18	680 0.3×	740 0.6×	598 0.6×	464 0.7×	268 0.6×	31	1.5k
Ellie Maghami United States	17	457 0.2×	359 0.3×	525 0.5×	396 0.6×	303 0.7×	50	1.3k

Countries citing papers authored by Harlan Pinto

Since Specialization

Citations

This map shows the geographic impact of Harlan Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harlan Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harlan Pinto more than expected).

Fields of papers citing papers by Harlan Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harlan Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harlan Pinto. The network helps show where Harlan Pinto may publish in the future.

Co-authorship network of co-authors of Harlan Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Harlan Pinto. A scholar is included among the top collaborators of Harlan Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harlan Pinto. Harlan Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernandez‐Pol, Sebastian, Henning Stehr, Carlos J. Suarez, et al.. (2025). MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis. npj Precision Oncology. 9(1). 34–34. 2 indexed citations

Khanna, Vishesh, Sebastian Fernandez‐Pol, Henning Stehr, et al.. (2024). MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis. 1 indexed citations

Divi, Vasu, Sumaira Z. Aasi, Saad A. Khan, et al.. (2024). Neoadjuvant Atezolizumab in Patients With Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma. 4 indexed citations

Pinto, Harlan, Quynh‐Thu Le, Andrew Quon, et al.. (2023). In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation. PLoS ONE. 18(2). e0276651–e0276651. 1 indexed citations

Leeolou, Melissa C., Carolyn Lee, Arash Momeni, et al.. (2022). Recurrent bilateral cutaneous squamous cell carcinoma arising within hypertrophic lichen planus with metastasis while on cemiplimab. JAAD Case Reports. 29. 55–58.

Chang, Kenneth J., Tony Reid, Neil Senzer, et al.. (2012). Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer. Gastrointestinal Endoscopy. 75(6). 1139–1146.e2. 36 indexed citations

Daly, Megan E., Quynh‐Thu Le, Anshu Jain, et al.. (2010). Intensity‐modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head & Neck. 33(1). 103–111. 24 indexed citations

Daly, Megan E., Quynh‐Thu Le, Peter G. Maxim, et al.. (2009). Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: Clinical Outcomes and Patterns of Failure. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1339–1346. 91 indexed citations

Le, Quynh‐Thu, Albert C. Koong, Balasubramanian Narasimhan, et al.. (2008). In Vivo 1H Magnetic Resonance Spectroscopy of Lactate in Patients With Stage IV Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 71(4). 1151–1157. 19 indexed citations

10.

Fakhry, Carole, William H. Westra, S. Li, et al.. (2008). Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial. JNCI Journal of the National Cancer Institute. 100(4). 261–269. 2122 indexed citations breakdown →

11.

Fakhry, Carole, William H. Westra, S. Li, et al.. (2007). Prognostic significance of human papillomavirus (HPV) tumor status for patients with head and neck squamous cell carcinoma (HNSCC) in a prospective, multi-center phase II clinical trial. Journal of Clinical Oncology. 25(18_suppl). 6000–6000. 6 indexed citations

12.

Daly, Megan E., Todd Pawlicki, Harlan Pinto, et al.. (2006). Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head & Neck. 29(3). 211–220. 67 indexed citations

13.

Cmelak, Anthony J., Meredith A. Goldwasser, Barbara A. Murphy, et al.. (2005). A phase II trial of chemoradiation (CR) for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx (L) or oropharynx (OP): A trial of the Eastern Cooperative Oncology Group (E2399). Journal of Clinical Oncology. 23(16_suppl). 5509–5509. 3 indexed citations

14.

Sivanandan, Ranjiv, Michael J. Kaplan, Harlan Pinto, et al.. (2004). Long-term Results of 100 Consecutive Comprehensive Neck Dissections. Archives of Otolaryngology - Head and Neck Surgery. 130(12). 1369–1369. 26 indexed citations

15.

Mehta, Vivek, Harlan Pinto, Jerry Halpern, et al.. (2004). Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. International Journal of Radiation Oncology*Biology*Physics. 60(1). 171–177. 91 indexed citations

16.

Horst, Kathleen C., et al.. (2003). Quality-of-life assessment in a phase II randomized trial of tirapazamine in advanced squamous cell carcinomas of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 57(2). S223–S224. 2 indexed citations

17.

McCaskill‐Stevens, Worta, et al.. (1999). Recruiting Minority Cancer Patients Into Cancer Clinical Trials: A Pilot Project Involving the Eastern Cooperative Oncology Group and the National Medical Association. Journal of Clinical Oncology. 17(3). 1029–1029. 94 indexed citations

18.

Tate, David J., John R. Adler, Steven D. Chang, et al.. (1999). Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. International Journal of Radiation Oncology*Biology*Physics. 45(4). 915–921. 62 indexed citations

19.

Gabalski, Edward C., Markus Adam, Harlan Pinto, et al.. (1998). Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers. The Laryngoscope. 108(12). 1856–1860. 21 indexed citations

20.

Jacobs, Charlotte & Harlan Pinto. (1995). Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter.. PubMed. 22(6). 540–52. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact